Leukemia risk following Hodgkin's disease: Relation to cumulative dose of alkylating agents, treatment with teniposide combinations, number of episodes of chemotherapy, and bone marrow damage

F. E. Van Leeuwen, A. M J Chorus, A. W. Van Den Belt-Dusebout, A. Hagenbeek, R. Noyon, E. H M Van Kerkhoff, H. M. Pinedo, R. Somers

Research output: Contribution to journal › Article › peer-review

157 Scopus citations

Fingerprint

Dive into the research topics of 'Leukemia risk following Hodgkin's disease: Relation to cumulative dose of alkylating agents, treatment with teniposide combinations, number of episodes of chemotherapy, and bone marrow damage'. Together they form a unique fingerprint.

Medicine & Life Sciences